MarketPR
AACPApogee Acquisition Corp files 8-K to restate Q2 financial statementsOct 21EQPTEquipmentShare raises 2026 rental revenue growth outlook to 43%Oct 21CLFCleveland-Cliffs reports Q3 2026 net income of $165 millionOct 21MKSIMKS Inc. agrees to sell Ophir Optics to TTM Technologies for $650 millionOct 21SLNMerck KGaA to Acquire Silence Therapeutics in $1.3 Billion Cash DealOct 21SLGNSilgan Forms Metal Packaging Partnership With AIP FundsOct 21GEGE Aerospace raises 2026 guidance on record engine ordersOct 21INSMInsmed adds Sanofi and Verily executives to boardOct 21MAMastercard Q2 Revenue Beats Gross Dollar Volume GrowthOct 21REGULATORYKiffin blames SEC schedule for LSU strugglesOct 21AACPApogee Acquisition Corp files 8-K to restate Q2 financial statementsOct 21EQPTEquipmentShare raises 2026 rental revenue growth outlook to 43%Oct 21CLFCleveland-Cliffs reports Q3 2026 net income of $165 millionOct 21MKSIMKS Inc. agrees to sell Ophir Optics to TTM Technologies for $650 millionOct 21SLNMerck KGaA to Acquire Silence Therapeutics in $1.3 Billion Cash DealOct 21SLGNSilgan Forms Metal Packaging Partnership With AIP FundsOct 21GEGE Aerospace raises 2026 guidance on record engine ordersOct 21INSMInsmed adds Sanofi and Verily executives to boardOct 21MAMastercard Q2 Revenue Beats Gross Dollar Volume GrowthOct 21REGULATORYKiffin blames SEC schedule for LSU strugglesOct 21
NewsMacro

Pomerantz class action names ChampionX Corporation; CHX investors face upcoming deadlines

A securities class action against ChampionX Corporation (NASDAQ: CHX) is in focus after Pomerantz LLP announced it has filed suit on behalf of investors who recorded losses on their holdings in the company. The New York law firm issued its reminder on July 16, 2026. Upcoming deadlines for affected shareholders to participate are now the next definitive date on the tape.

By Renata OstrowskiMacro DeskJuly 16, 20262 min read
Share

Key takeaways

  • Pomerantz LLP has filed a securities class action against ChampionX Corporation (NASDAQ: CHX) on behalf of investors who lost money on the stock.
  • The firm issued its reminder to affected shareholders on July 16, 2026.
  • The specific deadline for affected shareholders to participate has not been disclosed in the release.
  • CHX investors are directed to contact Danielle Peyton at [email protected] or 646-581-9980.
  • Pomerantz urges investors who believe their ChampionX losses qualify to make contact without waiting for additional notices.

A securities class action against ChampionX Corporation (NASDAQ: CHX) is in focus after Pomerantz LLP announced it has filed suit on behalf of investors who recorded losses on their holdings in the company. The New York law firm issued its reminder on July 16, 2026. Upcoming deadlines for affected shareholders to participate are now the next definitive date on the tape.

The action

Pomerantz LLP is targeting investors who suffered losses on ChampionX stock and is soliciting shareholders who believe they qualify to step forward before the relevant filing deadline. That deadline has not been disclosed in this release. Direct contact with the firm is the fastest way to confirm the window.

Securities class actions allow investors with similar claims to pursue them collectively. Participation deadlines in these cases typically determine who can take an active role in the litigation as it proceeds.

How to reach Pomerantz

The firm is directing interested CHX investors to Danielle Peyton. She is reachable at [email protected] or by phone at 646-581-9980. Investors who believe their ChampionX losses qualify them should not wait for additional notices before making contact.

What to watch

The upcoming filing deadline is the next concrete marker for CHX holders following this development. How many investors file and what role they take will shape the litigation's early direction. For shareholders who recorded losses on ChampionX and have not yet reviewed their options, the Pomerantz contact window is the date to track.

About this story

Filed by the macro desk of MarketPR on July 16, 2026. Source: prnewswire.com. Indicative figures are not investment advice.

←Back to the news index

More from the Newsroom

All stories →
01Macro

Outstanding margin debt hits $1.5 trillion, a record high

Outstanding margin debt has reached $1.5 trillion, marking a new all-time high. This level of leverage represents the fourth time since 1997 that outstanding margin debt has surged by at least 65% over a short period. The previous three…

Grant Halloran2 min read
02Macro

Berkshire stock hits post-Buffett high as Bending Spoons stake gains

Berkshire Hathaway shares closed Friday at their highest level since Warren Buffett announced in May 2025 that he planned to step down as CEO at the end of that year. Class A shares (BRK.A) ended the session at $798,000, while Class B…

Grant Halloran2 min read
03Macro

Vanguard S&P 500 ETF offers 0.03% expense ratio for $1,000 investment

The Vanguard S&P 500 ETF (VOO) charges an expense ratio of 0.03%, a cost that amounts to $0.30 on a $1,000 investment. The fund, which holds approximately $1.7 trillion in assets, provides exposure to the S&P 500 index, a benchmark…

Grant Halloran2 min read

Frequently asked

Who filed the class action and against whom?

Pomerantz LLP, a New York law firm, filed the securities class action against ChampionX Corporation (NASDAQ: CHX) on behalf of investors who suffered losses on their holdings.

What is the deadline for shareholders to participate?

The specific filing deadline has not been disclosed in this release; investors are advised to contact the firm directly to confirm the window.

How can affected investors reach Pomerantz?

Interested CHX investors can contact Danielle Peyton at [email protected] or by phone at 646-581-9980.

Who is eligible to participate in the action?

Investors who recorded losses on their ChampionX stock and believe they qualify are being solicited to step forward before the relevant filing deadline.

What should CHX holders watch for next?

The upcoming filing deadline is the next concrete marker, as the number of investors who file and the roles they take will shape the litigation's early direction.